Do not use any Nara Organics powdered infant formula that was on the U.S. market: the June 13, 2026 FDA-posted company announcement recalls all lots, not only the lot codes reproduced below. The affected products are the 700-gram can with UPC 860013251901 and the 400-gram can with UPC 860013251918, distributed nationwide through Target stores, Target.com, and Nara.com from July 2025 through June 2026. Stop feeding it, preserve the label information, follow current FDA instructions, and contact a health care provider immediately if an infant may have symptoms.
The controlling record is the FDA recall announcement. The FDA infant botulism investigation page carries the changing case investigation and handling instructions. This page is a product-specific identification and action guide; it is not a diagnosis, a substitute for a clinician, or a claim that every child who used the formula is ill.
Identify the recalled Nara Organics formula in one minute
Start with the brand, product form, package size, and UPC. Do not start by asking whether the lot appears in a copied list, because the announcement covers all lots of the Nara Organics powdered infant formula then on the market. A clear photograph of the front, UPC panel, bottom or lot panel, and use-by date creates a better record than a typed code alone. Keep the container away from other formula so it cannot be used by mistake.
| Identifier | Recalled product | What to record |
|---|---|---|
| Brand and form | Nara Organics powdered infant formula | Front label and a note that the product is powder, not a different Nara-branded item |
| Package size | 700 g | Net-weight panel and the complete UPC 860013251901 |
| Package size | 400 g | Net-weight panel and the complete UPC 860013251918 |
| Distribution window | July 2025 through June 2026 in the United States | Store or website, purchase date, order number, and receipt when available |
| Recall scope | All lots currently on the market when announced | Lot code and use-by date for tracing, even if the code is not in a copied example list |
The FDA announcement says the product was distributed nationwide through Target stores, Target.com, and Nara.com and was not distributed outside the United States. Purchase channel helps document the transaction, but it does not narrow an all-lot recall. A can obtained from another person may still match the recalled product even when the current holder has no receipt.
Why a lot-code nonmatch does not clear this product
The recall announcement lists codes that help users and investigators transcribe labels, but its scope statement is broader: all lots on the market are recalled. That hierarchy matters. A missing digit, a rubbed label, a packaging variation, or a lot not included in a secondary article must not be turned into permission to use the formula. Use the UPC and package identity to recognize the product, then save whatever lot and date information remains readable for a refund, report, or public-health follow-up.
| Lot codes printed in the FDA announcement | Lot codes printed in the FDA announcement |
|---|---|
| 408125075E14F2 | 708125076E14F2 |
| 708125083E14F2 | 408125139E14F2 |
| 708125141E14F2 | 708125145E14F2 |
| 708125174E14F2 | 709125273E14F2 |
| 709125280E14F2 | 709125288E14F2 |
| 409125307E14F2 | 70926019ENNB |
| 70926029ENNB | 70926035ENNB |
| 70926039ENNB | 70926042ENNB |
This table is a transcription aid, not an inclusion test. If the label says Nara Organics powdered infant formula and matches one of the recalled sizes and UPCs, follow the all-lot instruction even when the visible code is absent from the table. Check the live FDA announcement before relying on any saved or printed version of this page.
Use a stop, document, check, and escalate decision path
A useful recall page should produce an action, not just repeat a headline. First prevent another feeding. Next document the container and purchase. Then read the current official instructions. Finally, choose the health, reporting, and refund path that fits the facts. Do not taste the formula, prepare another bottle to test it, or wait for a retailer email before stopping use.
| Situation | Immediate action | Next official step |
|---|---|---|
| Matching Nara product is unopened | Separate it, label it DO NOT USE, and photograph all identifiers | Follow the FDA and seller instructions for return, refund, or disposal |
| Matching product is open but no symptoms are apparent | Stop use and prevent accidental reuse; preserve photos and feeding dates | Read the current FDA investigation handling guidance and contact a clinician with questions |
| Infant may have a listed symptom | Contact a health care provider immediately; urgent breathing or swallowing difficulty requires emergency help | Give the provider the product, lot, use-by date, feeding timeline, and FDA recall link |
| Label or lot is unreadable | Use brand, powder form, size, UPC, purchase channel, and photographs | Treat an otherwise matching product as covered by the all-lot instruction and ask the official contact if needed |
| A secondary website says the code is not recalled | Do not resume use based on that result | Return to the live FDA scope statement, which controls this guide |
For products from another brand, use the broader infant formula recall check guide. It owns the generic lookup intent. This Nara page stays narrowly focused on one named all-lot recall so the scope cannot be diluted by unrelated formula notices.
Know the symptom escalation boundary
FDA’s investigation material lists possible infant botulism signs that can include constipation, poor feeding, loss of head control, and difficulty swallowing. It warns that illness may progress to difficulty breathing or respiratory arrest and that symptoms can take weeks to appear. A web page cannot determine whether a symptom is botulism or whether exposure caused an illness. The safe boundary is to contact a health care provider immediately when an infant who consumed the product may have symptoms and to seek emergency assistance for urgent breathing or swallowing problems.
On the review date, the ongoing FDA investigation reported four illnesses, four hospitalizations, no deaths, and cases in California, Pennsylvania, and Washington, with the latest listed illness onset on May 31, 2026. Those figures are a dated snapshot, not a ceiling on risk and not a list of the only places where recalled cans were sold. Read the current page for later case counts, states, and instructions.
Preserve the evidence a clinician or investigator can use
The evidence record should be factual and time ordered. Save identifiers before a return or disposal makes them unavailable. If the container is open, follow the current FDA investigation guidance about safe retention rather than mailing or transporting a sample on your own. FDA’s review-date guidance says to photograph the can and identifiers and considers retaining an opened can, clearly marked DO NOT USE and stored safely away from other formula, for at least one month in case a health department requests testing. Recheck the live instructions because handling advice can change.
| Evidence item | Exact detail to save | Why it matters |
|---|---|---|
| Product identity | Front label, powder form, 400 g or 700 g size, and full UPC | Establishes whether the container matches the named recalled product |
| Trace code | Lot code and use-by date exactly as printed, with photographs | Supports a seller, manufacturer, FDA, or health-department trace even though all lots are covered |
| Purchase record | Retailer or website, purchase date, order number, quantity, and receipt | Supports refund and distribution tracing without proving medical causation |
| Use timeline | Dates and approximate times the infant consumed it and when use stopped | Gives a clinician a clearer factual history than a general recollection |
| Health notes | Observed signs, their timing, provider contacted, and advice received | Preserves observations without self-diagnosing or changing medical instructions |
| Official record | FDA URL and the date and time checked | Separates current federal guidance from screenshots or reposted summaries |
Report a problem and handle the refund separately
Use the FDA Report a Problem page to choose the appropriate reporting route for an adverse event or product complaint. A report does not replace medical care, and a refund request does not create a health report. Keep confirmation numbers from each process separate. If a retailer or manufacturer asks for the container, first preserve clear identifier photos and follow any current public-health retention instruction.
The recall refund and replacement guide helps organize receipts, seller contacts, and outcomes. It should not be used to bargain away a safety instruction or to assume that receiving a refund closes an FDA or clinical follow-up.
Use FDA records without turning a search result into a safety guarantee
The FDA information for parents and caregivers is the best starting point for current federal infant-formula notices and caregiver instructions. Our FDA food recall check guide explains how to match a food by product name, package, UPC, lot, date, and distribution. The FDA recall list guide explains why a database search can miss spelling variations, newly posted records, or a product described under a company name.
A result showing no other recall is not a certification that a product is safe. Recall pages address a defined action and scope; they do not inspect the can in your home, diagnose an infant, or cover every possible quality problem. For this Nara recall, the named all-lot announcement controls the decision, and current clinical advice controls health care.
Nara Organics recall questions
Is only one Nara Organics lot recalled?
No. The June 13, 2026 FDA-posted announcement says all lots of the Nara Organics powdered infant formula currently on the market are recalled. The printed lot list is useful for transcription and tracing, not for clearing a different-looking lot.
What if the can has already been opened?
Stop using it, prevent accidental reuse, photograph the identifiers, and read the current FDA investigation instructions. On the review date, FDA advised considering safe, clearly labeled retention of an opened can for at least one month in case a health department requests testing. Do not send or handle a sample without official direction.
Does no symptom today mean the infant is cleared?
No web guide can provide that clearance. FDA notes that symptoms can take weeks to appear. Contact a health care provider with exposure or symptom questions, and obtain urgent help for difficulty breathing or swallowing.
Can I use the formula if I bought it outside the listed dates?
Do not infer safety from a receipt date alone. Match the product and UPC, read the live FDA scope, and ask the official recall contact when the distribution history is unclear. The published window describes known distribution; it is not a home inspection.
Recall scope, investigation totals, medical guidance, and product-handling instructions can change. Recheck the live FDA pages. Last reviewed August 6, 2026.